Baird lowered the firm’s price target on UnitedHealth (UNH) to $356 from $510 and keeps an Outperform rating on the shares. The firm updated its model following its current business update and appointment of its new CEO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target lowered to $374 from $563 at Morgan Stanley
- UnitedHealth price target lowered to $362 from $521 at Deutsche Bank
- UnitedHealth price target lowered to $351 from $677 at Wells Fargo
- UnitedHealth CEO Transition Amid Financial Uncertainty
- UnitedHealth downgraded to Neutral at BofA amid MA uncertainty